Customer Success Stories
In the demanding world of clinical research, it is helpful to learn from the innovative use cases of sponsors who have used PHT's ePRO systems to achieve their research goals.
Merck Research Laboratories:
Insomnia Study
What if you could reduce your sample size by half?
When you collect better data, you can do more with fewer patients - thereby saving significant cost and shortening your trial. An insomnia study performed by Merck was the first randomized trial to compare the relative abilities of paper and eDiaries to show efficacy. The study found that PRO data collected by the LogPad exhibited a 35% lower standard deviation than paper diary data. Merck calculated that this reduced variance would have enabled them to achieve study power with 56% fewer patients if they had used the LogPad instead of paper. Estimating a conservative $6,000 per patient, that reduction would have saved approximately $340,000. Read more about the trial.
Asthmatx Inc.:
AIR2 Trial - Phase III
How sites really feel about using ePRO
The AIR2 Trial, a pivotal Phase III study sponsored by Asthmatx, investigates the safety and effectiveness of Bronchial Thermoplasty™, the first non-drug treatment for asthma, using the Alair® System. 300 patients at 35 global sites use the LogPad to record and transmit daily symptomatic data on their experiences following treatment. Two principal investigators took to time to tell PHT about the benefits and challenges of using ePRO in a trial. Find out what they said.
Temple University:
COPD Disease Management Study
Can a call center and a LogPad reduce hospitalizations and improve QoL?
Temple's unique disease management study uses the LogPad to investigate the impact of a pulmonary call center on COPD patient hospitalizations, deaths, lung function and quality of life. The LogPad uses automatic graded scoring and real-time alerts at the site to identify warning signs of exacerbations, and notifies patients when they need to contact the call center based on these scores. Early results have reduced hospitalizations significantly - but don't take our word for it. To learn more, read the case study or watch the news report, which features patient and study coordinator interviews.
Learn More about PHT Client Success Stories
What other evidence of ePRO ROI, or innovative use cases, does PHT have? I have a unique trial requirement and I'm not sure if there is an existing product that addresses it - can PHT help me develop a custom solution? Contact PHT for answers to these questions or any others you may have.
